Lead Product(s): S007-867
Therapeutic Area: Cardiology/Vascular Diseases Product Name: S007-867
Highest Development Status: IND Enabling Product Type: Small molecule
Partner/Sponsor/Collaborator: Marc Laboratories
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement June 12, 2021
The agreement has been signed for the development of a synthetic compound S-007-867 as modulator of blood coagulation cascade, in particular as inhibitor of collagen induced platelet aggregation.